LobbyingPike Therapeutics lobbying by quarter
Pike Therapeutics's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2024; the issues it reports most are Health Issues.
Pike Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2024 | $9,500 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$9,500 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Ipolicy Solutions | $9,500 | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor, and Pensions | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | Ipolicy Solutions | Under $5,000 |
| 04/13for Q1 | Ipolicy Solutions | Under $5,000 |
| 01/16for Q4 2025 | Ipolicy Solutions | Under $5,000 |
| 25/10/15for Q3 2025 | Ipolicy Solutions | Under $5,000 |
| 25/07/16for Q2 2025 | Ipolicy Solutions | Under $5,000 |
| 25/04/11for Q1 2025 | Ipolicy Solutions | Under $5,000 |
| 25/01/24for Q4 2024 | Ipolicy Solutions | Under $5,000 |
| 24/10/17for Q3 2024 | Ipolicy Solutions | Under $5,000 |
| 24/07/17for Q2 2024 | Ipolicy Solutions | $9,500 |
| 24/05/15for Q2 2024 | Ipolicy Solutions | Under $5,000 |